Viewing Study NCT06232551


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-03 @ 4:51 PM
Study NCT ID: NCT06232551
Status: RECRUITING
Last Update Posted: 2024-07-17
First Post: 2024-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Sponsor: Scott C. Woller, MD
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 1052468
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View